Literature DB >> 12404097

Marfan syndrome in the third Millennium.

Gwenaëlle Collod-Béroud1, Catherine Boileau.   

Abstract

The Marfan syndrome (MFS) is a prominent member of heritable disorders of connective tissue with manifestations involving primarily the skeletal, ocular and cardiovascular systems but also and less systematically investigated the lung, skin and integument, and dura. Over the last two decades, a considerable amount of clinical, molecular and protein data had accumulated. In combination with the study of natural and transgenic animal models, this new information provides greater insight into the pathogenic mechanisms underlying not only the pleiotropic manifestations of MFS but also the important degree of clinical variability (age of onset and severity) observed between patients. The following aspects will be described in this review: the structure and function of fibrillin-1; the fibrillin proteins; mutations in the FBN1 gene and pathogenic mechanisms; animal models. Finally, the currently available laboratory diagnostic tests and their limits will be discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404097      PMCID: PMC2695985          DOI: 10.1038/sj.ejhg.5200876

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  61 in total

1.  The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue.

Authors:  V A McKUSICK
Journal:  Circulation       Date:  1955-03       Impact factor: 29.690

2.  Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts.

Authors:  D M Milewicz; R E Pyeritz; E S Crawford; P H Byers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Abnormal morphology of fibrillin microfibrils in fibroblast cultures from patients with neonatal Marfan syndrome.

Authors:  M Godfrey; M Raghunath; J Cisler; C L Bevins; A DePaepe; M Di Rocco; J Gregoritch; K Imaizumi; P Kaplan; Y Kuroki
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

4.  Fibulin-2: genetic mapping and exclusion as a candidate gene in Marfan syndrome type 2.

Authors:  G Collod; M L Chu; T Sasaki; M Coulon; R Timpl; L Renkart; J Weissenbach; G Jondeau; J P Bourdarias; C Junien; C Boileau
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

5.  Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms.

Authors:  T Aoyama; U Francke; H C Dietz; H Furthmayr
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 6.  Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.

Authors:  H C Dietz; R E Pyeritz
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150

7.  Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome.

Authors:  K Kainulainen; L Karttunen; L Puhakka; L Sakai; L Peltonen
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

8.  A comparison of the Berlin and Ghent nosologies and the influence of dural ectasia in the diagnosis of Marfan syndrome.

Authors:  P S Rose; H P Levy; N U Ahn; P D Sponseller; T Magyari; J Davis; C A Francomano
Journal:  Genet Med       Date:  2000 Sep-Oct       Impact factor: 8.822

9.  The Tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils.

Authors:  C M Kielty; M Raghunath; L D Siracusa; M J Sherratt; R Peters; C A Shuttleworth; S A Jimenez
Journal:  J Cell Biol       Date:  1998-03-09       Impact factor: 10.539

10.  Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.

Authors:  H Zhang; W Hu; F Ramirez
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

View more
  27 in total

1.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

2.  ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation.

Authors:  Carine Le Goff; Fanny Morice-Picard; Nathalie Dagoneau; Lauren W Wang; Claire Perrot; Yanick J Crow; Florence Bauer; Elisabeth Flori; Catherine Prost-Squarcioni; Deborah Krakow; Gaoxiang Ge; Daniel S Greenspan; Damien Bonnet; Martine Le Merrer; Arnold Munnich; Suneel S Apte; Valérie Cormier-Daire
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

3.  Lysyl oxidase deficiency: a new cause of human arterial dissection.

Authors:  I Sibon; P Sommer; J M Daniel Lamaziere; J Bonnet
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 4.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

5.  Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome.

Authors:  Svend Rand-Hendriksen; Rigmor Lundby; Lena Tjeldhorn; Kai Andersen; Jon Offstad; Svein Ove Semb; Hans-Jørgen Smith; Benedicte Paus; Odd Geiran
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

6.  Two novel mutations of FBN1 in Jordanian patients with Marfan syndrome.

Authors:  Saied A Jaradat; Lama A Abujamous; Ali A Al-Hawamdeh; Khaldoon M Alawneh; Tamara A Rawashdeh; Zaher M Jaradat
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Heterozygous TGFBR2 mutations in Marfan syndrome.

Authors:  Takeshi Mizuguchi; Gwenaëlle Collod-Beroud; Takushi Akiyama; Marianne Abifadel; Naoki Harada; Takayuki Morisaki; Delphine Allard; Mathilde Varret; Mireille Claustres; Hiroko Morisaki; Makoto Ihara; Akira Kinoshita; Koh-ichiro Yoshiura; Claudine Junien; Tadashi Kajii; Guillaume Jondeau; Tohru Ohta; Tatsuya Kishino; Yoichi Furukawa; Yusuke Nakamura; Norio Niikawa; Catherine Boileau; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2004-07-04       Impact factor: 38.330

8.  Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients.

Authors:  Tomomi Uyeda; Toru Takahashi; Shuji Eto; Takumi Sato; Gang Xu; Rika Kanezaki; Tsutomu Toki; Susumu Yonesaka; Etsuro Ito
Journal:  J Hum Genet       Date:  2004-06-23       Impact factor: 3.172

9.  Fibrillin-1 in incisional hernias: an immunohistochemical study in scar and non-scar regions of human skin and muscle fasciae.

Authors:  Martin Fricke; Claus Langer; Edgar Brunner; Lynn Y Sakai; Laszlo Füzesi; Dieter P Reinhardt; Fabio Quondamatteo
Journal:  J Anat       Date:  2008-04-10       Impact factor: 2.610

10.  Two novel FBN1 mutations associated with ectopia lentis and marfanoid habitus in two Chinese families.

Authors:  Liming Zhao; Ting Liang; Jianzhen Xu; Hui Lin; Dandan Li; Yanhua Qi
Journal:  Mol Vis       Date:  2009-04-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.